HACQUETIASAPONIN-4;3-O-{BETA-D-GLUCUPYRANOSYL-(1->2)-[ALPHA-L-ARABINOPYRANOSYL-(1->3)]-BETA-D-GLUCURONOPYRANOSYL-(1->)}-21-(2-ACETOXY
Compound with spectra: 1 NMR
![HACQUETIASAPONIN-4;3-O-{BETA-D-GLUCUPYRANOSYL-(1->2)-[ALPHA-L-ARABINOPYRANOSYL-(1->3)]-BETA-D-GLUCURONOPYRANOSYL-(1->)}-21-(2-ACETOXY](/api/compound/I5TWKGYbpH0.png?ph=true&h=300&w=458 "HACQUETIASAPONIN-4;3-O-{BETA-D-GLUCUPYRANOSYL-(1->2)-[ALPHA-L-ARABINOPYRANOSYL-(1->3)]-BETA-D-GLUCURONOPYRANOSYL-(1->)}-21-(2-ACETOXY")
| SpectraBase Compound ID | I5TWKGYbpH0 |
|---|---|
| InChI | InChI=1S/C56H88O25/c1-12-54(10,81-24(3)60)49(72)80-43-44(74-23(2)59)56(22-58)26(19-50(43,4)5)25-13-14-30-52(8)17-16-31(51(6,7)29(52)15-18-53(30,9)55(25,11)41(68)42(56)69)76-48-40(79-47-36(66)34(64)33(63)28(20-57)75-47)38(37(67)39(78-48)45(70)71)77-46-35(65)32(62)27(61)21-73-46/h13,26-44,46-48,57-58,61-69H,12,14-22H2,1-11H3,(H,70,71)/t26-,27-,28+,29-,30+,31-,32-,33+,34-,35+,36+,37-,38-,39-,40+,41-,42+,43-,44-,46-,47-,48+,52-,53+,54?,55-,56-/m0/s1 |
| InChIKey | LDONPZOLBXIGGE-BXSQKEIBSA-N |
| Mol Weight | 1161.3 g/mol |
| Molecular Formula | C56H88O25 |
| Exact Mass | 1160.561468 g/mol |
| Enantiomer InChIKey | LDONPZOLBXIGGE-GHHRWIPDSA-N |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | C5D5N |
2-Propenoic acid, 3-phenyl-, 1,1a,1b,1c,2a,3,3a,4,6a,6b,7,8-dodecahydro-3a,6b-dihydroxy-1,1,5,7-tetramethyl-4-oxo-2a-[[(1-oxo-3-phenyl-2-propenyl)oxy]methyl]-8aH-cyclopropa[5',6']benz[1',2':7,8]az uleno[5,6-b]oxirene-8,8a-diyl ester, [1aR-(1a.alpha.,1b.beta.,1c.beta.,2a.beta.,3a.beta.,6a.alpha.,6b.alpha.,7.alpha.,8.beta.,8a.alpha.)]-
Spiro[12,15:17,20-dietheno-6H,16H,22H-dibenzo[b,d][1,6,12,22]tetraox acycloheptacosin-16,4'-piperidine]-1,31-dimethanamine, 7,8,9,10,23,24,25,26-octahydro-N,N,N',N',1',13,19,32,35-nonamethyl-, (S)-
2-(2'-acetoxymethyl-3'-(2",3",4"-tri(trimethylsiloxy).alpha.-L-rhamnosyloxy)-4'-(2"-phenyl-2"-trimethylsiloxyethylcarbonyloxy)-5'-(2"-methylpropylcarbonylamino)-1'-oxacycloheh-1'-yloxy)-4,4-di(trimethylsiloxycarbonyl)-8,13-ethano-15-hydroxy-16-methylene-perhydrophenanthrane
tetramethyl (2.alpha.,3.alpha.,6.beta.,8.beta.,10.beta.,12.beta.,15.alpha.,16.alpha.)-19-endo,23-endo,27-exo-9,21-dioxo-7,11,19,23,27,28-hexaoxaundecacyclo[15.7.2.1(2,16),1(4,14).0(1,17).0(3,15).0(5,13).0(6,8).0(10,12).0(18,20).0(22,24)]octacosa-5(13),25-diene-3,15,25,26-tetracarboxylate
1,1,2',2'-Tetraethyl-1',2',3',8',9',10',11',23',34',35',36',35'a-dodecahydro-14'-20'-38'-41'-tetramethylspiro[piperidine-4,17'-[4,6:13,16:18,21]trietheno[28,32:31,35]dimethano[17H][1,6,16,21]tetraoxacyclotriacontino[25,24-c]pyridinium]Dichloride
6H,13H-5,13:6,12-Dietheno-5a,12a-(methaniminomethano)-1H,5H,8H,12H-[1,2,4]triazolo[1,2-a][1,2,4]triazolo[1',2':1,2]pyridazino[4,5-d]pyridazine-18-acetic acid, 2,3,9,10-tetrahydro-.alpha.-(2-methylpropyl)-1,3,8,10,17,19-hexaoxo-2,9-diphenyl-, hexyl ester, stereoisomer
41,42,43,44,45,46,47,48-Octamethoxy-4,9,14,19,24,29,34,39-octamethylnonacyclo[35.3.1.1(2,6).1(7,11).1(12,16).1(17,21).1(22,26).1(27,31).1(32,36)]octatetraconta-1(41),2,4,6(48),7,9,11(47),12,14,16(46),17,19,21(45),22,24,26(44),27,29,31(43),32,34,36(42),37,39-tetracosaene
13',16':18',21'-dietheno-1,1''-diethyl-3',14',20',31'-tetramethyldispiro[piperidine-4,17'-[5,12,22,29]tetraoxa[37,40,41]triazatetracyclo[31.13.1.0.(4,45).0(30,35)]heptatetraconta-1',3',13',15',18',20',30',34',35',45'-decaene-47',4''-piperidine]-38',42'-dione
.alpha.-isomer of 1-(1-(1'-(2",3",6",8"-tetramethyl-4",5"-di(2"-methoxycarbonylethyl)-7"-acetylporphinyl)ethoxy)ethyl)-3-(1-(1'-(2",4",5",8"-tetramethyl-3"-acetyl-6",7"-di(2"-methoxycarbonylethyl)porphinyl)ethoxy)ethyl)-2,4,5,8-tetramethyl6,7-di(2-methoxycarbonylethyl)porphine
1,7,2,6-Ethanediylidene-6a,10c-(methaniminomethano)-3H,6H,7H,8H-2b,4, 5a,7a,9,10a-hexaazadicyclopent[d,i]acenaphthylene-12-acetic acid, 1-bromooctahydro-.alpha.-(2-methylpropyl)-3,5,8,10,11,13-hexaoxo-4,9- diphenyl-, hexyl ester, (S)-
| Title | Journal or Book | Year |
|---|---|---|
| Saponins from Hacquetia epipactis | Phytochemistry | 1995 |